尿肾脏损伤因子-1与产后出血所致急性肾损伤的关系及诊断价值

doi:10.3969/j.issn.1671-2587.2018.04.022

临床输血与检验 ›› 2018, Vol. 20 ›› Issue (4): 407-411.DOI: 10.3969/j.issn.1671-2587.2018.04.022

尿肾脏损伤因子-1与产后出血所致急性肾损伤的关系及诊断价值

李平华

054000 河北省冀中能源邢台矿业集团有限责任公司总医院产科

收稿日期:2018-02-17 出版日期:2018-08-20 发布日期:2018-08-14
作者简介:李平华（1981–）,女,主治医师,主要从事产科危重症早期识别及治疗工作,（Tel）15931992353（E-mail）Lipinghua1981@163.com。

The Diagnostic Value of Urine Kidney Injury Molecule-1 in Patients with Acute Kidney Injury of Postpartum Hemorrhage

LI Ping-hua.

Department of Obstetrical,The General Hospital of Hebei Jizhong energy xingtai mining Group Co,LTD,Xingtai,Hebei,054000

Received:2018-02-17 Online:2018-08-20 Published:2018-08-14

摘要/Abstract

摘要： 目的探讨尿肾脏损伤因子-1（KIM-1）与产后出血所致急性肾损伤（AKI）的关系及诊断价值。方法回顾性分析2013年7月~2016年5月医院收治的185例产后出血孕产妇临床资料，按照AKI诊断标准分为AKI组46例和非AKI组139例，采用尿试纸试验检查患者尿隐血和尿蛋白含量，碱性苦味酸法检测血肌酐（SCr）值，酶联免疫吸附试验检测尿KIM-1水平。Logistic回归分析影响AKI的危险因素，利用受试者工作特征曲线（ROC）预测KIM-1及其他指标对AKI的诊断价值。结果 AKI组SCr、尿KIM-1、产后出血量、妊娠糖尿病发生率、妊娠高血压发生率、胎盘早剥发生率、先兆子痫发生率、尿蛋白阳性率、尿隐血阳性率均明显高于非AKI组，差异有统计学意义（均P＜0.05）。相关分析显示，AKI患者尿KIM-1水平与产后出血量、尿蛋白、尿隐血、SCr呈明显正相关（r=0.798，0.630，0.600，0.887，均P＜0.05），与其余指标的相关性无统计学意义（P＞0.05）。Logistic多因素回归分析显示，尿蛋白、尿隐血、SCr、尿KIM-1是影响AKI患者的危险因素（均P＜0.05）。ROC曲线分析显示，尿KIM-1诊断AKI的最佳临界值为5.21 ng/mL，敏感度为78.4%，特异度为82.9%，ROC曲线下面积（AUC）为0.811（95%CI：0.649～0.929，P＜0.05），尿KIM-1诊断AKI的AUC高于尿蛋白（AUC：0.732，95%CI：0.600～0.864，P＜0.05）、尿隐血（AUC：0.758，95%CI：0.634～0.882，P＜0.05）、SCr（AUC：0.676，95%CI：0.539～0.813，P＜0.05）。结论尿KIM-1是影响AKI的危险因素，检测尿KIM-1能够为诊断AKI提供参考。

关键词: 肾脏损伤因子-1, 产后出血, 急性肾损伤, 诊断

Abstract: Objective To explore the correlation and its diagnostic value between urine kidney injury molecule-1（KIM-1） levels and acute kidney injury （AKI） in the patients with postpartum hemorrhage. Methods Clinical data of 185 cases of postpartum hemorrhage were retrospectively analysed，according to AKI diagnostic criteria. The patients were divided into 46 cases of AKI group and 139 cases of non-AKI group. The urine occult blood and protein were detected by urine paper test，serum creatinine level was detected by alkaline picric acid method，urine KIM-1 level was determined by ELISA. The AKI risk factors was analysed by logistic regression. The diagnostic value of urine KIM-1 and other indicators for AKI were evaluated by receiver operating curve （ROC）. Results The SCr，urine KIM-1，postpartum hemorrhage volume and the rates of gestational diabetes，gestational hypertension，placental abruption，preeclampsia，positive urinary protein，positive urine occult blood in AKI group were significantly higher than those in non-AKI group （all P＜0.05）. The urine KIM-1 level was positively correlated with urine protein，urine occult blood and SCr in AKI patients （r=0.798，0.630，0.600，0.887，P＜0.05），and no correlation of other indexes were found. Logistic multivariate regression analysis showed that urine KIM-1，protein，occult blood，and SCr were risk factors for AKI （all P＜0.05）. The optimal cut-off value of urine KIM-1 as an indicator for AKI diagnosis was projected to be 5.21 ng/mL，which yielded a sensitivity of 78.4% and a specificity of 82.9% with an area under the curve （AUC） of 0.811 （95%CI：0.649～0.929，P＜0.05）. The AUC of urine KIM-1 for KAI diagnosis was higher than urine protein （AUC：0.732，95%CI：0.600～0.864，P＜0.05），urine occult blood （AUC：0.758，95%CI：0.634～0.882，P＜0.05），and SCr （AUC：0.676，95%CI：0.539～0.813，P＜0.05）. Conclusion Urinary KIM-1 is a risk factor for AKI and detection of KIM-1 may provide a reference for the diagnosis of AKI.

Key words: Kidney injury molecule-1, Postpartum hemorrhage , Acute kidney injury , Diagnosis

中图分类号:

R446.1 R692

李平华. 尿肾脏损伤因子-1与产后出血所致急性肾损伤的关系及诊断价值[J]. 临床输血与检验, 2018, 20(4): 407-411.

LI Ping-hua.. The Diagnostic Value of Urine Kidney Injury Molecule-1 in Patients with Acute Kidney Injury of Postpartum Hemorrhage[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(4): 407-411.

参考文献

1 岳金凤，吴大玮，李琛等.以急性肾损伤网络标准评估重症监护病房患者急性肾损伤的发病率、预后及死亡相关危险因素[J].中华医学杂志，2011，91（4）：260-264.
2 Tsurkan MV，Hauser PV，Zieris A，et al. Growth factor delivery from hydrogel particle aggregates to promote tubular regeneration after acute kidney injury[J]. J Control Release，2013，167（3）：248-255.
3 Ricci Z，Netto R，Garisto C，et al. Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatric RIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery：Cross-sectional study[J]. Pediatr Crit Care Med，2012，13（6）：667-670.
4 许红阳，臧芝栋，严洁，等.NGAL对成人心脏术后急性肾损伤的早期诊断价值[J].东南大学学报（医学版），2012，31（1）：67-71.
5 Liang XL，Liu SX，Chen YH，et al. Combination of urinary kidney injury molecule-1 and interleukin-18 as early biomarker for the diagnosis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery：a prospective nested case-control study[J]. Biomarkers，2010，15（4）：332-339.
6 Aydo du M，Gürsel G，Sancak B，et al. The use of plasma and urine neutrophil gelatinase associated lipocalin （NGAL） and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients[J]. Dis Markers，2013，34（4）：237-246.
7 Vaidya VS，Ozer JS，Dieterle F，et al.Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies[J]. Nat Biotechnol，2010，28（5）：478-485.
8 泽毅. 中华妇产科学[M]. 北京：人民卫生出版社，1999：495.
9 James M，Bouchard J，Ho J，et al. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury[J]. Am J Kidney Dis，2013，61（5）：673-685.
10 Bellomo R，Ronco C，Kellum JA，et al. Acute renal failure - definition，outcome measures，animal models，fluid therapy and information technology needs：the Second International Consensus Conference of the Acute Dialysis Quality Initiative （ADQI） Group.[J]. Crit Care，2004，8（4）：R204-212.
11 Verbrugge FH，Dupont M，Shao Z，et al.Novel urinary biomarkers in detecting acute kidney injury，persistent renal impairment，and all-cause mortality following decongestive therapy in acute decompensated heart failure[J]. J Card Fail，2013，19（9）：621-628.
12 Harel Z，Wald R，Bargman JM，et al.Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors[J]. Kidney Int，2013，83（5）：901-908.
13 Parikh CR，Han G. Variation in performance of kidney injury biomarkers due to cause of acute kidney injury[J]. Am J Kidney Dis，2013，62（6）：1023-1026..
14 孔祥雷，张成银，马小静，等.不同的基于血肌酐估测肾小球滤过率公式对健康成年人肾功能的评价[J].中华检验医学杂志，2013，36（3）：242-245.
15 Cuadros T，Trilla E，Vilà MR，et al.Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progression[J]. Eur J Cancer，2013，49（8）：2034-2047.
16 Humphreys BD，Xu F，Sabbisetti V，et al.Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis[J]. J Clin Invest，2013，123（9）：4023-4035.
17 黄菁，郑美玲，王玉珏，等.尿肾损伤分子1、血清胱抑素C和尿中性粒细胞明胶酶相关性脂质运载蛋白预测子痫前期发病和早期肾损伤的价值[J].中国医科大学学报，2016，45（5）：460-463. （下转406页）
18 陆任华，方燕，高嘉元，等.住院患者急性肾损伤的发病及预后相关危险因素分析[J].中华肾脏病杂志，2012，28（3）：194-200.
19 李青霖，程庆砾，马强，等.老年急性肾损伤患者短期预后及危险因素分析[J].中华医学杂志，2013，93（34）：2715-2718.
20 Palviainen M，Raekallio M，Rajam?ki MM，et al.Kidney-derived proteins in urine as biomarkers of induced acute kidney injury in sheep[J]. Vet J，2012，193（1）：287-289.
21 Abassi Z，Shalabi A，Sohotnik R，et al.Urinary NGAL and KIM-1：Biomarkers for assessment of acute ischemic kidney injury following nephron sparing surgery[J]. J Urol，2013，189（4）：1559-1566.
22 刘丹，张翼飞，卢宏柱，等.窒息新生儿尿肾脏损伤因子-1检测在早期诊断急性肾损伤中的价值[J].广东医学，2013，34（3）：386-388.

[1]	李翠莹. 胎儿新生儿溶血病的诊疗策略探讨^*[J]. 临床输血与检验, 2021, 23(1): 24-28.
[2]	陈姜, 向洪洲, 李政, 张莹. STAT3在胰腺癌辅助诊断及预后中的价值^*[J]. 临床输血与检验, 2020, 22(2): 156-160.
[3]	卞茂红, 钟涛, 朱帮强, 闻慧琴, 胡海亮. 留学生《实验诊断学》实验课程国际化建设初探^*[J]. 临床输血与检验, 2020, 22(2): 218-220.
[4]	金梅, 马丹冬. 血清丙酸对感染性休克早期诊断及预后的评估价值[J]. 临床输血与检验, 2020, 22(1): 58-63.
[5]	蔡学琴, 王保龙. 肺癌自身抗体对肺结节良恶性鉴别的临床价值[J]. 临床输血与检验, 2020, 22(1): 82-85.
[6]	饶楚炳. 血清和尿液穿透素-3对危重症患者近期急性肾损伤的预测价值[J]. 临床输血与检验, 2020, 22(1): 104-108.
[7]	杨玉萍, 杨旭东. 同型半胱氨酸、脂蛋白a及脂蛋白磷脂酶A2联合检测对冠心病的诊断价值^*[J]. 临床输血与检验, 2019, 21(6): 561-563.
[8]	王贵强, 林新梅, 冯均建, 张莉, 卫茂华. 血清KL-6在输血相关性急性肺损伤中应用价值研究[J]. 临床输血与检验, 2019, 21(5): 449-453.
[9]	许晓红, 刘纪君. 中孕期二联和三联血清学产前筛查效率的比对分析[J]. 临床输血与检验, 2019, 21(5): 506-509.
[10]	张克昌, 谢瑞玉, 李维春. 炎症指标及细胞因子检测在新生儿败血症早期诊断中的应用价值^*[J]. 临床输血与检验, 2019, 21(4): 435-437.
[11]	惠朝晖, 张永, 顶石琼, 梅马芳, 张磊, 龙国海, 钟达宏. 血清炎性因子联合检测对动脉粥样硬化的诊断价值^*[J]. 临床输血与检验, 2019, 21(3): 289-293.
[12]	翟荣荣. 单核细胞与淋巴细胞比值联合SAT-TB法对于涂阴肺结核的鉴别诊断价值[J]. 临床输血与检验, 2019, 21(3): 297-301.
[13]	饶楚炳. 动态监测外周血CPNE3对急性心肌梗死的诊断价值[J]. 临床输血与检验, 2019, 21(3): 308-312.
[14]	阳军. IL-17/NF-kB p65通路相关因子对急性脑出血病情和预后的诊断价值[J]. 临床输血与检验, 2019, 21(3): 313-317.
[15]	李莉, 危蕾, 王众福, 马伟, 刘芳英, 钱叶长. 联合检测血清CXCL14、TNF-α、KL-6、SP-D在特发性肺间质纤维化诊断中的临床价值^*[J]. 临床输血与检验, 2019, 21(2): 177-179.

尿肾脏损伤因子-1与产后出血所致急性肾损伤的关系及诊断价值

The Diagnostic Value of Urine Kidney Injury Molecule-1 in Patients with Acute Kidney Injury of Postpartum Hemorrhage

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们